Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors.
about
Structural mechanism of trimeric HIV-1 envelope glycoprotein activationHIV-1 cell to cell transfer across an Env-induced, actin-dependent synapseAccess of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles.Inhibition of human immunodeficiency virus type 1 infectivity by the gp41 core: role of a conserved hydrophobic cavity in membrane fusionStructural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis.Mutations that destabilize the gp41 core are determinants for stabilizing the simian immunodeficiency virus-CPmac envelope glycoprotein complexRole of a Putative gp41 Dimerization Domain in Human Immunodeficiency Virus Type 1 Membrane FusionConformational Changes in the Capsid of a Calicivirus upon Interaction with Its Functional ReceptorSensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop regionEvidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug targetA synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusionHIV-1 Env C2-V4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscapeDilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.Substitutions in the receptor-binding domain of the avian sarcoma and leukosis virus envelope uncouple receptor-triggered structural rearrangements in the surface and transmembrane subunitsPhysiological levels of virion-associated human immunodeficiency virus type 1 envelope induce coreceptor-dependent calcium flux.Use of the quartz crystal microbalance to monitor ligand-induced conformational rearrangements in HIV-1 envelope protein gp120.Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cellsLow pH-induced conformational changes in vesicular stomatitis virus glycoprotein involve dramatic structure reorganization.Mode of action of an antiviral peptide from HIV-1. Inhibition at a post-lipid mixing stage.Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state.HIV-1 envelope determinants for cell tropism and chemokine receptor use.Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophagesRecognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.Conformational intermediates and fusion activity of influenza virus hemagglutinin.Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion.Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activityFunctional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.Mutations within the putative membrane-spanning domain of the simian immunodeficiency virus transmembrane glycoprotein define the minimal requirements for fusion, incorporation, and infectivity.NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligandRegulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation.C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
P2860
Q21131394-9DEBE837-0DE2-4F45-95B4-9B590B81675BQ22242967-83922422-57D0-4AD0-8FBE-80ACBEA7A891Q24645530-AFF21AFD-6095-46AC-8936-90C3CC181FC2Q24791794-595642F1-1284-4B59-9586-9F6149875BA6Q27619600-91B6D1A6-5694-4832-BF76-A7E7E3FDE186Q27635422-AA1D9E86-0A47-491E-96A7-E75FA506A4BEQ27637675-8A2B3021-4A3E-427A-8965-C3BA2F7E653EQ27657871-455A120A-5DC2-4547-A9F1-AEFAC37D2B92Q27660383-CD607DEB-71FE-451A-A4DA-949E15122A0EQ28343901-AE96C6BD-1983-4B60-97D8-1D702977F54CQ28369397-3887F203-1565-454B-92CF-15BBFE949528Q28379574-69E9F2C0-B7F0-48BE-8418-4E021A0D0165Q28487168-B48CE5D2-5709-4FFD-8847-A23D787EAD94Q30442126-844EE55E-CA07-4B56-9EB0-534FAD1B7ED4Q30448472-7F31C2F3-3DCA-4708-B351-94192F7D6A7FQ30453519-63CB0D4B-5D9D-43DE-A774-C646E5208857Q30478990-5E628BA2-2313-4A42-A0C8-A4914077BB7FQ30480515-8CCFE834-598E-4CB4-81B4-D84AA90D1813Q30706865-8555A2F6-9094-46E9-8FA6-EE659955B40AQ30865013-51541A81-F72D-4BBC-BA49-4DC4933DE51EQ31452195-29727618-FFB0-466F-B346-89B78443AA8FQ31454800-93FA9DA3-2FB6-47B6-96B9-13B47B2AC3DAQ33426352-DAF73A67-512F-4E09-85C0-B654D50B73E0Q33637946-4DA2FCE7-052F-459E-88CA-8B9BF83976ACQ33787402-D24CB3AA-E34C-4D6E-91C9-377D57D8168AQ33807129-D14913A1-54D6-4E5A-A131-361B27F5C615Q33807605-4FBB664A-0927-4C88-9343-5745A7FA5D58Q33808920-0E0A4841-9A81-4F4F-A8D1-CEEDA395A06DQ33809112-40D5231B-A25B-4E7B-8815-CDA853D8B26AQ33813444-9FF53C75-48AC-48EF-A0D9-947024D6C9ACQ33815984-A1AE9D6E-9CAB-4E5B-A48C-2B69B322B89BQ33825418-BDDF7EE1-B7DB-49CE-99FF-080984B6108AQ33826951-15491164-D95C-46C7-83DB-C69D084B7E76Q33843696-6E741BC3-A238-4A34-A20C-8031A48AE19EQ33846366-D553B4D4-2CD4-4AB9-BC1A-3E84DC915F04Q33906133-A96B3857-D21F-45BB-8B2B-347012759BEBQ33984243-67BD039C-4786-4B84-BD7D-B4DC081A2555Q34225654-0DE392CB-542A-4300-8BAB-5778B88989A5Q34345536-6D9CDA75-A4DF-40D0-9B90-BED4C5E9E0D2Q34359035-5AD8DE64-8127-473F-A3DF-CB243827CECB
P2860
Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Conformational changes in cell ...... surface CD4 and co-receptors.
@en
Conformational changes in cell ...... surface CD4 and co-receptors.
@nl
type
label
Conformational changes in cell ...... surface CD4 and co-receptors.
@en
Conformational changes in cell ...... surface CD4 and co-receptors.
@nl
prefLabel
Conformational changes in cell ...... surface CD4 and co-receptors.
@en
Conformational changes in cell ...... surface CD4 and co-receptors.
@nl
P2093
P2860
P356
P1476
Conformational changes in cell ...... surface CD4 and co-receptors.
@en
P2093
P2860
P304
P356
10.1074/JBC.273.1.404
P407
P577
1998-01-01T00:00:00Z